Sneddon's syndrome: Clinical and laboratory analysis of 10 cases

Acta Medica Okayama

Volumn 58, Issue 2, 2004, Pages 59-65

  Bolayir, Ertugrul ^a   Yilmaz, Abdulkerim ^a   Kugu, Nesim ^a   Erdogan, Haydar ^a   Akyol, Melih ^a   Akyuz, Aytekin ^a  

^a CUMHURIYET UNIVERSITY   (Turkey)

Author keywords

Antiphospholipid antibodies; Cognitive functions; Genetics; Migraine; Sneddon's syndrome

Indexed keywords

ANTITHROMBIN III; PHOSPHOLIPID ANTIBODY;

ADULT; ARTICLE; AUTOSOMAL DOMINANT INHERITANCE; BRAIN INFARCTION; CEREBROVASCULAR DISEASE; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; DEPRESSION; EPILEPSY; FEMALE; HEMIANOPIA; HUMAN; LABORATORY DIAGNOSIS; LIVEDO RETICULARIS; MEDICAL ASSESSMENT; MEDICAL LITERATURE; MYASTHENIA GRAVIS; SNEDDON SYNDROME;

ADULT; ANTIBODIES, ANTIPHOSPHOLIPID; BIOPSY; CEREBROVASCULAR ACCIDENT; FEMALE; HUMANS; PEDIGREE; SNEDDON SYNDROME;

EID: 3042647133     PISSN: 0386300X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (34)

1. Sneddon IB: Cerebro-vascular lesions and livedo reticularis. Br J Dermatol (1965) 77: 180-185.
2. Pinol Aquade J, Ferrandiz C, Ferrer Roca O and Ingelmo M: Livedo reticularis and cerebro-vascular. Med Cutan Ibero Lat Am (1975) 3: 257-265.
3. Deschamps P, Leroy D, Mandard JC, Heron JF and Lauret P: Livedo reticularis and nodules due to cholesterol embolism in the lower extremities. Br J Dermatol (1977) 97: 93-97.
4. Zelger B, Sepp N, Stockhammer G, Dosch E, Hilty E, Ofner D, Aichner F and Fritsh PO: Sneddon's syndrome. A long-term follow-up of 21 patients. Arch Dermatol (1993) 129: 437-447.
5. Rebollo M, Val JF, Garijo F, Quintana F and Berciano J: Livedo reticularis and cerebrovascular lesions (Sneddon's syndrome). Clinical, radiological and pathological features in eight cases. Brain (1983) 106: 965-979.
6. Jonas J, Kolble K, Volcker HE and Kalden JR: Central retinal artery occlusion in Sneddon's disease associated with antiphospholipid antibodies. Am J Ophthalmol (1986) 102: 37-40.
7. Vargas JA, Yebra M, Pascual ML, Manzano L and Durantez A: Antiphospholipid antibodies and Sneddon's syndrome. Am J Med (1989) 87: 597.
8. Stockhammer G, Felber SR, Zelger B, Sepp N, Birbamer GG, Fritsch PO and Aichner FT: Sneddon's syndrome: Diagnosis by skin biopsy and MRI in 17 patients. Stroke (1993) 24: 685-690.
9. Karagulle AT, Karadag D, Erden A and Erden I: Sneddon's syndrome: MR imaging findings. Eur Radiol (2002) 12: 144-146.
10. Farronay OW, Kalashnikova LA, Verschaguin NV, Lozhnikova SM, Liudkovskaya IG, Borisenko W, Usman VB and Morgunov VA: Cerebrovascular and immunological studies in Sneddon's syndrome. Ann Neurol (1992) 32: 266.
11. Quimby SR and Perry HO: Livedo reticularis and cerebrovascular accidents. J Am Acad Dermatol (1980) 3: 377-383.
12. Bradly W: Neurological complications of systemic disease; in Neurology in Clinical Practice, Daraffe R, Fenicel G and Marsden D eds, 3th Ed, Botterworth- Heinemann, New York (2000) pp 1025-1026.
13. Stockhammer GJ, Felber SR, Aichner FT, Zelger B, Sepp N and Fritsch P: Sneddon's syndrome antiphospholipid antibodies: Clarification of a controversy by skin biopsy? Stroke (1992) 23: 1182-1183.
14. Kalashnikova LA, Nasonov EL, Borisenko VV, Usman VB, Prudnikova LZ, Kovaljov VU and Kushekbaeva AF: Sneddon's syndrome: Cardiac pathology and antiphospholipid antibodies. Clin Exp Rheumatol (1991) 9: 357-361.
15. Donnet A, Khalil R, Terrier G, Koeppel MC, Njee BT and Aillaud MF: Cerebral infarction, livedo reticularis, and familial deficiency in antithrombin III (letter). Stroke (1992) 23: 611-612.
16. Bolayir E, Kececi H, Akyol M, Tas A and Polat M: Sneddon's syndrome and antithrombin III. J Dermatol (1999) 26: 532-534.
17. Matsushita S, Fujisao S and Nishimura Y: Molecular mechanisms underlying HLA-DR-associated susceptibility to autoimmunity. Int J Cardiol (1996) 54: S81-S90.
18. Dowd PM: Reaction to cold: in Textbook of Dermatology. Champion RH, Burton JL, Burns DA and Breatnach SM eds, Blacwell- Science, Oxford (1998) pp 957-972.
19. Tietjen GE, Al-Qasmi MM and Shukairy MS: Livedo reticularis and migraine: A marker for stroke risk? Headache (2002) 42: 352-355.
20. Tietjen GE, Gottwald L, Al-Qasmi MM, Gunda P and Khuder SA: Migraine is associated with livedo reticularis: A prospective study. Headache (2002) 42: 263-267.
21. Stephens WP and Ferguson IT: Livedo reticularis and cerebro-vascular disease. Postgrad Med J (1982) 58: 70-73.
22. Rumpl E and Rumpl H: Recurrent transient global amnesia in a case with cerebrovascular lesions and livedo reticularis (Sneddon Syndrome). J Neurol (1979) 221: 127-131.
23. Thomas DJ, Kirby JD, Britton KE and Galton DJ: Livedo reticularis and neurological lesions. Br J Dermatol (1982) 106: 711-712.
24. Wohlrab J, Fischer M, Wolter M and Marsch WC: Diagnostic impact and sensitivity of skin biopsies in Sneddon's syndrome. A report of 15 cases. Br J Dermatol (2001) 145: 285-288.
25. Parmeggiani A, Posar A, De Giorgi LB, Sangiorgi S, Mochi M, Monari L, Patrizi A and Rossi PG: Sneddon syndrome, arylsulfatase A pseudodeficiency and impairment of cerebral white matter. Brain Dev (2000) 22: 390-393.
26. Blow RJ: Sneddon syndrome: CT, arteriography, and MR imaging. J Comput Assist Tomogr (1989) 13: 119-122.
27. Rehany U, Kassif Y and Rumelt S: Sneddon's Syndrome: Neuroophthalmologic manifestations in a possible autosomal ressesive pattern. Neurology (1998) 51: 1185-1187.
28. Mosnaim AD, Kulara H, Adams AJ, Wolf ME, Puente J, Freitag F and Diamond S: Flow cytometric analysis of lymphocyte subsets in migraine patients during and outside of an acute headache attack. Cephalalgia (1998) 18: 197-201.
29. Kalashnikova LA, Korczyn AD, Shavit S, Rebrova O, Reshetnyak T and Chapman J: Antibodies to prothrombin in patients with Sneddon's Syndrome. Neurology (1999) 53: 223-225.
30. Brey RL, Gharavi AE and Lockshin MD: Neurologic complication of antiphospholipid antibodies. Rheum Dis Clin Norh Am (1993) 19: 833-850.
31. Porta Etessam J, Balsalobre Aznar J, Gomez Pellico C, Nunez Lopez R, Luna Alcala A, Rodrigo Garzon M, Lopez Valdes E, Gomez de la Fuente E, Benito-Leon J and Basalobre Aznar MD: Clinical manifestations associated with antiphospholipid antibodies. An Med Interna (1997) 14: 636-646.
32. Shoenfeld Y, Lorber M, Yucel T and Yazici H: Primary antiphospholipid syndrome emerging following thymectomy for myasthenia gravis: Additional evidence for the kaleidoscope of autoimmunity. Lupus (1997) 6: 474-476.
33. Ebers GC and Sadovnich AD: The role of genetic factors in multiple sclerosis susceptibility. J Neuroimmunol (1994) 54: 1-17.
34. Martelletti P, Lulli P, Morellini M, Mariani B, Pennesi G, Cappellacci S, Brioli G, Giacovazzo M and Trabace S: Chromosome 6p-encoded HLA-DR2 determination discriminates migraine without aura from migraine with aura. Hum Immunol (1999) 60: 69-74.